Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?

被引：3
作者：
van Laar, Jacob M. [1 ]
机构：
[1] Univ Newcastle Upon Tyne, Sch Clin Med Sci, Inst Cellular Med, Musculoskeletal Res Grp,Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2007年 / 3卷 / 10期
关键词：
predictor; rheumatoid arthritis; rheumatoid factor; response; TNF;
D O I：
10.1038/ncprheum0596
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：544 / 545
页数：2
相关论文
共 50 条
  • [21] Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study
    Lopez-Medina, Clementina
    Calvo-Gutierrez, Jerusalem
    Abalos-Aguilera, M. Carmen
    Cepas, Francisco
    Plasencia-Rodriguez, Chamaida
    Martinez-Feito, Ana
    Balsa, Alejandro
    Fare-Garcia, Regina
    Juan-Mas, Antoni
    Ruiz-Esquide, Virginia
    Sainz, Luis
    Diaz-Torne, Cesar
    Godoy-Navarrete, Francisco Javier
    Anon-Onate, Isabel
    Mena-Vazquez, Natalia
    Manrique-Arija, Sara
    Moreno-Garcia, Marina Soledad
    Ortega-Castro, Rafaela
    Escudero-Contreras, Alejandro
    RMD OPEN, 2024, 10 (01):
  • [22] Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors
    Kathleen Tymms
    Geoff Littlejohn
    Hedley Griffiths
    Julien de Jager
    Paul Bird
    Fred Joshua
    Peter Nash
    Malcolm Handel
    Hamish McManus
    Belinda E. Butcher
    Peter Youssef
    Clinical Rheumatology, 2018, 37 : 1617 - 1623
  • [23] Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors
    Tymms, Kathleen
    Littlejohn, Geoff
    Griffiths, Hedley
    de Jager, Julien
    Bird, Paul
    Joshua, Fred
    Nash, Peter
    Handel, Malcolm
    McManus, Hamish
    Butcher, Belinda E.
    Youssef, Peter
    CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1617 - 1623
  • [24] Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis; analysis of GEO datasets
    Kim, Tae-Hwan
    Choi, Sung Jae
    Lee, Young Ho
    Song, Gwan Gyu
    Ji, Jong Bae
    JOINT BONE SPINE, 2014, 81 (04) : 325 - 330
  • [25] The kynurenine pathway in patients with rheumatoid arthritis during tumor necrosis factor α inhibitors treatment
    Witoszynska-Sobkowiak, Joanna
    Sikorska, Dorota
    Niklas, Karolina
    Zychowska, Iwona
    Rutkowski, Rafal
    Samborski, Wlodzimierz
    REUMATOLOGIA, 2024, 62 (04): : 220 - 225
  • [26] Nerve growth factor and brain-derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF-α blockers
    Del Porto, Flavia
    Aloe, Luigi
    Lagana, Bruno
    Triaca, Viviana
    Nofroni, Italo
    D'Amelio, Raffaele
    BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, 2006, 1069 : 438 - 443
  • [27] Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study
    Dubovyk, Violetta
    Vasileiadis, Georgios K.
    Fatima, Tahzeeb
    Zhang, Yuan
    Kapetanovic, Meliha Crnkic
    Kastbom, Alf
    Rizk, Milad
    Soederbergh, Annika
    Zhao, Sizheng Steven
    van Vollenhoven, Ronald F.
    Hetland, Merete Lund
    Haavardsholm, Espen A.
    Nordstrom, Dan
    Nurmohamed, Michael T.
    Gudbjornsson, Bjorn
    Lampa, Jon
    Ostergaard, Mikkel
    Heiberg, Marte Schrumpf
    Sokka-Isler, Tuulikki
    Grondal, Gerdur
    Lend, Kristina
    Horslev-Petersen, Kim
    Uhlig, Till
    Rudin, Anna
    Maglio, Cristina
    RMD OPEN, 2024, 10 (02):
  • [28] Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
    Genovese, Mark C.
    Fleischmann, Roy M.
    Greenwald, Maria
    Satterwhite, Julie
    Veenhuizen, Melissa
    Xie, Li
    Berclaz, Pierre-Yves
    Myers, Stephen
    Benichou, Olivier
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (09) : 1461 - 1468
  • [29] Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al
    Mercer, Louise K.
    Galloway, James B.
    Lunt, Mark
    Davies, Rebecca
    Low, Audrey A. L.
    Dixon, Will G.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (02)
  • [30] ASSOCIATION BETWEEN ETHNICITY AND INITIAL RESPONSE TO TNF INHIBITORS IN PEOPLE WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER FOR RHEUMATOID ARTHRITIS (BSRBR-RA)
    Tsoi, M. F.
    Andev, R. S.
    Kearsley-Fleet, L.
    Watson, K.
    Dubey, S.
    Kumar, K.
    Moorthy, A.
    Gupta, M.
    Adebajo, A.
    Hyrich, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1391 - 1392
12345